Your browser doesn't support javascript.
loading
Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival.
Shimose, Shigeo; Iwamoto, Hideki; Tanaka, Masatoshi; Niizeki, Takashi; Shirono, Tomotake; Kajiwara, Akira; Noda, Yu; Kamachi, Naoki; Okamura, Shusuke; Nakano, Masahito; Kuromatsu, Ryoko; Kawaguchi, Takumi; Koga, Hironori; Torimura, Takuji.
Afiliación
  • Shimose S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Iwamoto H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Tanaka M; Iwamoto Internal Medical Clinic, Kitakyushu, Japan.
  • Niizeki T; Clinical Research Center, Yokokura Hospital, Miyama, Japan.
  • Shirono T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kajiwara A; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Noda Y; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kamachi N; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Okamura S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Nakano M; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kuromatsu R; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kawaguchi T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Koga H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Torimura T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Oncology ; 99(12): 756-765, 2021.
Article en En | MEDLINE | ID: mdl-34518483
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Quinolinas / Quimioembolización Terapéutica / Carcinoma Hepatocelular / Progresión de la Enfermedad / Sorafenib / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Quinolinas / Quimioembolización Terapéutica / Carcinoma Hepatocelular / Progresión de la Enfermedad / Sorafenib / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Año: 2021 Tipo del documento: Article País de afiliación: Japón